Overview Request Sample Pages Request Customization Download PDF
You are viewing: Europe Urology Devices Market analysis
Part of: Urology Devices Market (Global)

The Europe Urology Devices Market was valued at $5057.8 Million in 2025 and projected to reach to $6635.8 Million by 2030, representing a compound annual growth rate of 5.6%. Europe's urology devices market is positioned for steady growth through 2030, supported by an aging population, rising healthcare expenditure, and increasing awareness of urological health.

Europe Urology Devices Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Urology Devices Market Trends and Insights

  • Europe maintains a significant share of the global urology devices market, driven by advanced healthcare infrastructure, aging populations, and high prevalence of urological conditions across the region.
  • The market in Europe is characterized by strong regulatory frameworks, established reimbursement systems, and a concentration of leading medical device manufacturers. Growth in Europe's urology devices market is supported by increasing adoption of minimally invasive procedures, technological innovations in diagnostic and therapeutic devices, and rising healthcare expenditure.
  • Europe's aging demographic profile continues to drive demand for urological treatments, particularly for benign prostatic hyperplasia, urinary incontinence, and kidney stone management.
  • Between 2025 and 2030, Europe is expected to see steady expansion as healthcare providers invest in advanced urology equipment and patient awareness campaigns intensify across major European markets..

Key Market Statistics

  • CAGR (2025-2030) 5.6% CAGR
  • Market Size, 2025 ~USD 5057.8 Million
  • Forecast, 2030 ~USD 6635.8 Million
  • Geography Europe

Europe Urology Devices Market Overview

Market Valuation & Growth :

Europe's urology devices market is valued at $5,057.8 million in 2025 and is projected to reach $6,635.8 million by 2030, with a steady CAGR of 5.6%, reflecting robust demand across the region.

Advanced Healthcare Infrastructure :

Europe benefits from well-established healthcare systems, high reimbursement rates, and strong regulatory frameworks that support the adoption of innovative urology devices and minimally invasive treatment solutions.

Aging Population Dynamics :

Europe's aging demographic profile drives increased prevalence of urological conditions including benign prostatic hyperplasia, urinary incontinence, and kidney stones, creating sustained demand for diagnostic and therapeutic devices.

Regional Market Leadership :

Germany leads European market with $2,623.9 million, followed by the UK ($2,154.2 million) and France ($1,556.7 million), representing the continent's strongest healthcare spending and device adoption rates.

Europe Urology Devices Market Dynamics

  • The region's mature healthcare infrastructure and strong regulatory environment facilitate rapid adoption of advanced technologies including robotic-assisted surgery systems, laser lithotripsy devices, and digital diagnostic tools.
  • Key growth drivers include expanding endoscopic procedures, growing prevalence of urinary tract disorders, and increasing patient preference for minimally invasive treatments.
  • Healthcare providers across Europe are investing in state-of-the-art urology departments, further accelerating device market expansion.
  • Competitive pricing pressures and reimbursement challenges remain, yet innovation and clinical efficacy continue to drive market penetration across major European markets..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • Europe's urology devices market is valued at $5,057.8 million in 2025 and projected to reach $6,635.8 million by 2030 at a 5.6% CAGR.
    • Europe benefits from advanced healthcare infrastructure, strong regulatory frameworks, and established reimbursement systems that support market growth.
    • Aging populations and rising prevalence of urological conditions drive sustained demand for urology devices across Europe.
    • Minimally invasive procedures and technological innovations are key growth drivers in Europe's urology devices market through 2030.

    Urology Devices Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment URINARY INCONTINENCE (UI) (Application)
    Forecast Period 2025–2030
    Growth Rate CAGR of 6% from 2025 to 2030
    Largest Segment HOSPITALS (End User)
    Market Size Base Year (Billions) ~USD 34.57 (2025)
    Revenue Forecast (Billions) ~USD 46.26 (2030)
    Segments Covered Product, Type, Application, End User

    Europe Urology Devices Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Product

    • Consumables & Accessories
    • Instruments

    By Type

    • Biopsy Devices
    • Catheters
    • Cystoscopes
    • Dialysis Consumables
    • Dialysis Devices
    • Dilator Sets & Urethral Access Sheaths
    • Drainage Bags
    • Endoscopes
    • Endoscopy Fluid Management Systems
    • Endovision & Imaging Systems
    • External Catheters
    • Guidewires
    • Hemodialysis Devices
    • Indwelling/ Foley Catheters
    • Insufflators
    • Intermittent Catheters
    • Laparoscopes
    • Laser & Lithotripsy Devices
    • Nephroscopes
    • Other Consumables & Accessories
    • Other Instruments
    • Peritoneal Dialysis Devices
    • Resectoscopes
    • Retrieval Devices & Extractors
    • Robotic Systems
    • Stents And Implants
    • Surgical Dissectors, Forceps & Needle Holders
    • Tubes & Distal Attachments
    • Ureteroscopes
    • Urodynamic Systems

    By Application

    • Benign Prostatic Hyperplasia (Bph)
    • Erectile Dysfunction
    • Kidney Diseases
    • Other Applications
    • Pelvic Organ Prolapse
    • Urinary Incontinence (Ui)
    • Urinary Stones
    • Urological Cancer

    By End User

    • Ambulatory Surgery Centers
    • Clinics
    • Dialysis Centers
    • Home Care Settings
    • Hospitals

    REST OF EUROPE: UROLOGY DEVICES MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    AMBULATORY SURGERY CENTERS212217.5223.4234.2247.3263.5283.1309.66.7
    CLINICS31.832.433.134.536.238.340.944.56.1
    DIALYSIS CENTERS620.4648.1677.7723.3777.9843.79231027.68.7
    HOME CARE SETTINGS385.3400.6416.8442.6473.7511.2556.4616.48.1
    HOSPITALS1573.11620.91671.71759.41865.91995.62152.32362.47.2
    TOTAL2822.62919.53022.7319434013652.33955.74360.57.6

    EUROPE: UROLOGY DEVICES MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    AMBULATORY SURGERY CENTERS870.4883.8898.3931.8973.91026.71091.41181.15.6
    CLINICS133.8135136.5140.8146.2153.3161.9174.15
    DIALYSIS CENTERS1870.11935.22004.52119.32257.62425.72628.32898.67.7
    HOME CARE SETTINGS1268.31304.81343.51411.81495.11596.91720.11885.97
    HOSPITALS4822.34922.15028.55242.55507.55834.66233.967786.2
    TOTAL8964.99180.99411.39846.210380.311037.211835.612917.76.5

    Target Audience

    • Medical Device Manufacturers : Urology device companies need Europe-specific market data to develop localized product strategies, identify distribution partners, and optimize pricing for major European markets.
    • Healthcare Investors & PE Firms : Investment professionals require detailed market forecasts and regional growth drivers to evaluate acquisition targets, assess portfolio company performance, and identify emerging opportunities in European urology.
    • Hospital & Clinic Administrators : Healthcare facility leaders use market intelligence to benchmark procurement strategies, evaluate device adoption trends, and plan capital investments in urology departments across Europe.
    • Market Research & Consulting Firms : Research professionals leverage regional market data to support client advisory projects, competitive analysis, and strategic planning initiatives focused on European healthcare markets.
    • Government & Health Policy Bodies : Regulatory and policy organizations utilize market insights to inform healthcare spending decisions, reimbursement policies, and technology adoption guidelines for urology devices across Europe.

    Key Companies in the Europe Urology Devices Market

    CompanyHQOwnershipStrongest segments
    SIEMENS HEALTHINEERSGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
    NOVANTA, INCUnited StatesPublic CompanyPrecision Medicine and Manufacturing (lasers, beam steering, robotic motion, end-of-arm tooling, spindles),Medical Solutions (insufflators, pumps, disposables, imaging, RFID, light engines, OR integration),
    LUMENIS LTDIsraelPrivate CompanySurgical,Ophthalmic,Aesthetic,
    MERIT MEDICALUnited StatesPublic CompanyCardiovascular (cardiac and peripheral intervention, access, hemostasis, fluid and hemodynamic management),Oncology and Spine (soft tissue biopsy, vertebral augmentation, RFA, bone biopsy),Endoscopy (gastroenterology and pulmonary, including stents, cryoballoon, dilators, kits),
    FRESENIUS MEDICAL CARE AG & CO. KGAAGermanyPublic CompanyCare Delivery (dialysis clinics and services),Dialysis equipment and disposables,Renal pharmaceuticals and ancillary services,
    BOSTON SCIENTIFIC CORPORATIONUnited StatesPublic CompanyCardiovascular (structural heart, CRM, electrophysiology, peripheral interventions),MedSurg – Endoscopy (GI, pancreaticobiliary, infection prevention, single-use scopes),MedSurg – Urology and Pelvic Health,
    B. BRAUN MELSUNGEN AGGermanyPrivate CompanyInfusion therapy and smart infusion management,Sterile processing, OR supply, and surgical asset management,Standard and customized procedure kits,
    BECTON, DICKINSON AND COMPANYUnited StatesPublic CompanyMedical Essentials (med-surg disposables, injection, vascular access, sharps),Connected Care (infusion, medication management, pharmacy automation, informatics),BioPharma Systems (prefillable drug delivery systems),
    OLYMPUS CORPORATIONJapanPublic CompanyGastrointestinal Solutions,Surgical Endoscopes & Integrated OR,Urology Solutions,
    CARDINAL HEALTHUnited StatesPublic CompanyBranded Pharmaceutical Distribution,Generic and OTC Pharmaceutical Distribution,Specialty Pharmaceutical and Manufacturer Services,
    INTUITIVE SURGICALUnited StatesPublic Companyda Vinci systems (capital),da Vinci instruments, accessories, and stapling/energy,Ion endoluminal system and accessories,
    COLOPLAST A/SDenmarkPublic CompanyOstomy Care (SenSura Mio, SenSura, Brava),Continence Care (SpeediCath, Conveen, Peristeen),Advanced Wound Dressings and Biologics (Biatain, Comfeel),
    STRYKERUnited StatesPublic CompanyOrthopaedics (hips, knees, shoulders, ankle, trauma and extremities, Mako Shoulder-linked implants),MedSurg equipment and patient handling (surgical equipment, patient and caregiver safety, emergency and ICU disposables),Neurotechnology and stroke care (navigation, endoscopy, stroke and venous thromboembolism treatment, brain and skull procedures),
    TELEFLEX INCORPORATEDUnited StatesPublic CompanyVascular and Emergency Medicine (Arrow, EZ-IO, FAST1, QuikClot),Interventional (coronary, structural heart, peripheral, closure, OnControl),Surgical (Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, Titan SGS),
    CONVATEC GROUP PLCUnited KingdomPublic CompanyAdvanced Wound Care,Ostomy Care,Continence Care,
    MEDTRONIC PLCIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Diabetes),

    SIEMENS HEALTHINEERS

    Siemens Healthineers is a German public company founded in 1896 with 72,369 employees, operating in the healthcare technology sector.

    NOVANTA, INC

    Novanta, Inc. is a United States-based public company founded in 1968 with 3,000 employees.

    LUMENIS LTD

    Lumenis Ltd. is an Israeli private company founded in 1991 with 954 employees.

    MERIT MEDICAL

    Merit Medical is a United States-based public company founded in 1987 with 7,500 employees.

    FRESENIUS MEDICAL CARE AG & CO. KGAA

    Fresenius Medical Care AG & Co. KGaA is a German public company founded in 1996 with 108,165 employees, operating as a major healthcare provider.

    BOSTON SCIENTIFIC CORPORATION

    Boston Scientific Corporation is a United States-based public company founded in 1979 with 59,000 employees, specializing in medical devices.

    B. BRAUN MELSUNGEN AG

    B. Braun Melsungen AG is a German private company founded in 1839 with 61,583 employees, operating in the medical and pharmaceutical sectors.

    BECTON, DICKINSON AND COMPANY

    Becton, Dickinson and Company is a United States-based public company founded in 1897 with 72,000 employees, specializing in medical technology and diagnostics.

    OLYMPUS CORPORATION

    Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees, operating in imaging and medical technology.

    CARDINAL HEALTH

    Cardinal Health is a United States-based public company founded in 1979 with 55,392 employees, operating as a healthcare services and products distributor.

    INTUITIVE SURGICAL

    Intuitive Surgical is a United States-based public company founded in 1995 with 17,021 employees, specializing in robotic surgical systems.

    COLOPLAST A/S

    Coloplast A/S is a Danish public company founded in 1954 with 17,083 employees, specializing in medical devices and healthcare products.

    STRYKER

    Stryker is a United States-based public company founded in 1941 with 56,000 employees, operating in medical technology and surgical equipment.

    TELEFLEX INCORPORATED

    Teleflex Incorporated is a United States-based public company founded in 1943 with 15,500 employees, specializing in medical devices.

    CONVATEC GROUP PLC

    ConvaTec Group PLC is a United Kingdom-based public company founded in 1978 with 10,910 employees, operating in medical technology and healthcare products.

    MEDTRONIC PLC

    Medtronic PLC is an Ireland-based public company founded in 1949 with 95,000 employees, operating as a global leader in medical technology.

    Europe vs. other regions

    HowEurope compares to the other 3 regional blocs covered in this market.

    North America
    ~USD 7817.4 Million · 4.7% wtd CAGR ·
    Asia Pacific
    ~USD 5508.4 Million · 6.3% wtd CAGR ·
    Latin America
    ~USD 2183.6 Million · 3.4% wtd CAGR ·
    Middle East & Africa
    ~USD 1878.5 Million · 3.1% wtd CAGR ·

    Countries within Europe - compare and drill down

    Country2025 size (native)
    GermanyUSD 2623.9 Million
    UKUSD 2154.2 Million
    FranceUSD 1556.7 Million
    ItalyUSD 1008.9 Million
    SpainUSD 1213.5 Million
    Rest Of EuropeUSD 4360.5 Million

    Country market size visualization

    Germany
    USD 2623.9 Million
    UK
    USD 2154.2 Million
    France
    USD 1556.7 Million
    Italy
    USD 1008.9 Million
    Spain
    USD 1213.5 Million
    Rest Of Europe
    USD 4360.5 Million

    Reasons to Buy this Report

    • Regional Market Segmentation : Gain detailed insights into Europe's urology devices market with country-level breakdowns for Germany, UK, France, Italy, Spain, and Rest of Europe, enabling targeted market entry and expansion strategies.
    • Competitive Landscape Intelligence : Understand market dynamics, key players, and competitive positioning specific to Europe's mature healthcare environment, helping identify partnership and acquisition opportunities.
    • Growth Opportunity Identification : Leverage forecasted growth data (5.6% CAGR through 2030) to identify high-potential segments, emerging technologies, and underserved patient populations across European markets.
    • Regulatory & Reimbursement Insights : Access Europe-specific regulatory requirements, CE marking pathways, and reimbursement frameworks across major markets to accelerate product commercialization and market penetration.
    • Strategic Decision Support : Make informed investment, R&D, and commercialization decisions backed by comprehensive market sizing, trend analysis, and forecasts tailored to Europe's healthcare landscape.

    Frequently asked questions

    What is the current size of Europe's urology devices market?

    Europe's urology devices market is valued at $5,057.8 million in 2025 and is projected to grow to $6,635.8 million by 2030.

    What is the expected growth rate for Europe's urology devices market?

    Europe's urology devices market is expected to grow at a compound annual growth rate (CAGR) of 5.6% from 2025 to 2030.

    What factors are driving growth in Europe's urology devices market?

    Key growth drivers in Europe include aging populations, rising prevalence of urological conditions, adoption of minimally invasive procedures, technological innovations, and increased healthcare expenditure.

    Which urological conditions are most prevalent in Europe?

    Benign prostatic hyperplasia, urinary incontinence, and kidney stone disease are among the most prevalent urological conditions driving device demand across Europe.

    How does Europe's regulatory environment impact the urology devices market?

    Europe's strong regulatory frameworks, CE marking requirements, and established reimbursement systems create a structured market environment that supports innovation while ensuring device safety and efficacy.

    RESEARCH METHODOLOGY

    This research study extensively used secondary sources, directories, and databases to identify and collect valuable information to analyze the global urology devices market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative & quantitative information and assess the growth prospects in the market. The global market size estimated through secondary research was then triangulated with inputs from primary research to arrive at the final market size.

    Secondary Research

    Secondary research was used primarily to identify & collect information for the extensive, technical, market-oriented, and commercial study. The secondary sources used for this study include annual reports, SEC filings, investor presentations, World Health Organization (WHO), US Food and Drug Administration (US FDA), National Center for Biotechnology Information (NCBI), Health Canada, European Medicines Agency (EMA), and Centers for Disease Control and Prevention (CDC). These sources also obtained key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

    Primary Research

    In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify the critical qualitative & quantitative information and assess the prospects of the market. Various primary sources from both the supply & demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

    Urology Devices Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the urology devices market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Urology Devices Market : Top-Down and Bottom-Up Approach

    Urology Devices Market Top Down and Bottom Up Approach

    Data Triangulation

    The total market was split into several segments and subsegments after arriving at the overall market size from the estimation process. Where applicable, data triangulation and market breakdown procedures were employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Urology is a medical specialty that deals with the physiology, diseases, and disorders of the human urinary tract and male reproductive organs. Urology devices comprise various types of equipment used during the diagnosis, surgery, and treatment of urological diseases, such as chronic kidney diseases, renal failure, urinary stones, benign prostate hyperplasia (BPH), pelvic organ prolapse (POP), prostate cancer, kidney cancer, bladder cancer, and erectile dysfunction.

    Key Stakeholders

    • Manufacturers and Distributors of Urology Devices
    • Hospitals and ASCs
    • Academic Research Institutes
    • Urology Clinics
    • Urology Device Service Providers
    • Venture Capitalists and Investors
    • Clinical Research Organizations (CROs)

    Report Objectives

    • To define, describe, and forecast the urology devices market by product, application, end user, and region
    • To forecast the size of the urology devices market with respect to five regional segments, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
    • To provide detailed information regarding the major factors influencing market growth (drivers, restraints, opportunities, and challenges)
    • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall urology devices market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To profile the key players in the urology devices market and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies
    • To track and analyze competitive developments such as product launches, product approvals, mergers, agreements, collaborations, partnerships, expansions, and acquisitions in the urology devices market
    • To benchmark players within the urology devices market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

    To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, collaborations, and partnerships in the urology devices market

    Customization Options

    With the given market data, MarketsandMarkets offers customizations per the company’s specific needs. The following customization options are available for this report:

    Portfolio Assessment

    • Product Matrix gives a detailed comparison of the product portfolios of the top five companies.

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Geographical Analysis

    • A further breakdown of the Rest of Europe’s urology devices market into countries
    • A further breakdown of the Rest of Asia Pacific’s urology devices market into countries
    • A further breakdown of Latin America’s urology devices market into countries

    Get the Full Urology Devices Market Report

    Full forecast, segment splits, and company analysis for all Urology Devices Market.

    Download Sample Pages Buy Report

    METHODOLOGY

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    Cite this Research
    DMCA.com Protection Status